Omega-3 Dry Eye Formulation
Natural health product licensed in Canada
- Licence holder
- Nutricorp International
- NPN or DIN-HM
- 80057604
- Status
- Active licence
- Licence date
- 22 January 2015
- Revision date
- 10 February 2015
- Form
- Capsule, remplie de liquide
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Huile de poisson Source : Engraulidae - en entier Potency : 100 milligramme Docosahexaenoic acid | 334 milligramme |
| Huile de poisson Source : Clupeidae - en entier Potency : 100 milligramme Docosahexaenoic acid | 334 milligramme |
| Huile de poisson Source : Scombridae - en entier Potency : 100 milligramme Docosahexaenoic acid | 334 milligramme |
| Huile de poisson Source : Engraulidae - en entier Potency : 150 milligramme Eicosapentaenoic acid | Not specified |
| Linum usitatissimum Source : Linum usitatissimum - Graine | 334 milligramme |
| Huile de poisson Source : Clupeidae - en entier Potency : 150 milligramme Eicosapentaenoic acid | Not specified |
| Huile de poisson Source : Scombridae - en entier Potency : 150 milligramme Eicosapentaenoic acid | Not specified |
| Vitamine E | 40.9 milligramme |
Non-medicinal ingredients
Glycérine, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of EPA and DHA for the maintenance of good health. Helps maintain/support cardiovascular health. Helps support cognitive health and/or brain function. Source of essential fatty acids, omega-3 fatty acids, alpha-linolenic acid (ALA), omega- 6 fatty acids and linoleic acid (LA) for the maintenance of good health. Helps support proper tear function in persons with Dry Eye Syndrome. Helps decrease the rate of tear evaporation in persons with Dry Eye Syndrome. Helps decrease the rate of tear evaporation in persons with Dry Eye Syndrome. Helps provide relief/improve symptoms of Dry Eye Syndrome including support for proper tear function (decreased rate of tear evaporation and increase in tear secretion).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80057604
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2015. Photograph the packaging to check whether it has changed. Photograph the packaging